0

No products in the cart.

0

No products in the cart.

Home Business Lilly’s revenue soars 48%, driven by demand of its GLP-1s
Business

Lilly’s revenue soars 48%, driven by demand of its GLP-1s

Updated 1 day Ago1 Mins read2 Views
Share
Lilly’s revenue soars 48%, driven by demand of its GLP-1s
Share


Its sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.

Source link

Share
BenQ GV50 Review: Highly Portable, but With Quality Trade-Offs Previous post BenQ GV50 Review: Highly Portable, but With Quality Trade-Offs

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
How to earn a 9% dividend yield while cutting your risk in the stock market
Business

How to earn a 9% dividend yield while cutting your risk in the stock market

7 minutes Ago
Earnings call transcript: Chiron Real Estate Q2 2026 gains on strategy shift
Business

Earnings call transcript: Chiron Real Estate Q2 2026 gains on strategy shift

14 minutes Ago
Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 market
Business

Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 market

20 minutes Ago
My adult kids are big earners. Should I do a Roth conversion now so they aren’t taxed as much on their inheritance?
Business

My adult kids are big earners. Should I do a Roth conversion now so they aren’t taxed as much on their inheritance?

26 minutes Ago

Keep in touch

Subscribe to our newsletter to get our newest articles instantly!

    Copyright 2025. All rights reserved

    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com